SCHEMBL27378010

SCHEMBL27378010

NCc1cc(F)cc(-c2cnn(C3CCOC3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 5/20 0.46
▸ NTRK1 P04629 1/20 0.42
▸ MKNK1 Q9BUB5 2/20 0.41
▸ MKNK2 Q9HBH9 1/20 0.41
▸ JAK1 P23458 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ KIT P10721 1/20 0.38
▸ LRRK2 Q5S007 4/20 0.38
▸ IDO1 P14902 2/20 0.38
▸ TDO2 P48775 2/20 0.38
▸ MET P08581 2/20 0.37
▸ FGFR3 P22607 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ BRD4 O60885 1/20 0.36
▸ CREBBP Q92793 1/20 0.36
▸ ALK Q9UM73 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL31456977 0.91 MKNK1 (0.42) JAK2NTRK1MKNK1MKNK2JAK1
SCHEMBL21174101 0.86 PIK3CD (0.41) NTRK1METALK
Hydrochloric Acid SCHEMBL21174087 0.85 LOXL2 (0.42) NTRK1METALK
SCHEMBL27377996 0.77 MKNK1 (0.41) JAK2NTRK1MKNK1MKNK2JAK1
SCHEMBL30751335 0.77 MKNK1 (0.41) JAK2NTRK1MKNK1MKNK2JAK1
Trifluoroacetic Acid SCHEMBL31456989 0.76 ACHE (0.46) MET
Trifluoroacetic Acid SCHEMBL31457031 0.75 ACHE (0.46) MET
SCHEMBL21174253 0.73 LOXL2 (0.52) NTRK1METALK
SCHEMBL1951909 0.72 JAK2 (0.50) JAK2MKNK1MKNK2JAK1JAK3
Hydrochloric Acid SCHEMBL21174133 0.72 LOXL2 (0.53) NTRK1METALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024030000-A1 NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 넥스트젠바이오사이언스 2024-02-08 — — WO disclosed
Send feedback